There’s more to dietary ingredients’ potential in weight loss than being used to offset side effects of using GLP-1 drugs consumers are prescribed as obesity treatments, Metabolize.Life asserts in licensing two metabolites from Stanford University’s Office of Technology Licensing.
The Israeli startup launched earlier in 2024 by biomedical researcher and entrepreneur Morris Laster in July announced the agreement allows Metabolize to use research from the lab of Jonathan Long, associate professor pathology and ChEM-H Institute scholar at Stanford